Loma Linda Nephrology(@LLNeph) 's Twitter Profileg
Loma Linda Nephrology

@LLNeph

This account does not represent or speak on behalf of Loma Linda University Health.

ID:1290388758651523072

calendar_today03-08-2020 20:47:47

1,2K Tweets

633 Followers

35 Following

AJKD(@AJKDonline) 's Twitter Profile Photo

🎉 Congrats to Susan Koch-Weser et al who won the 'AJKD Editors' Choice: NKF Mission Award' for:

Development & Validation of the Rating of CKD Knowledge Among Older Adults (Know-CKD) with Kidney Failure

bit.ly/4adR0Q7 (FREE temporarily)

Tufts Medical Center Nephrology Team

🎉 Congrats to Susan Koch-Weser et al who won the 'AJKD Editors' Choice: NKF Mission Award' for: Development & Validation of the Rating of CKD Knowledge Among Older Adults (Know-CKD) with Kidney Failure bit.ly/4adR0Q7 (FREE temporarily) @TuftsMCKidney #NKFClinicals
account_circle
Noroژa(@n0r0zha) 's Twitter Profile Photo

I am deeply honored to have been selected as this year’s recipient of the prestigious GlomCon Physician Scientist (GPS) scholarship grant! GlomCon Loma Linda Nephrology

I am deeply honored to have been selected as this year’s recipient of the prestigious GlomCon Physician Scientist (GPS) scholarship grant! @GlomCon @LLNeph
account_circle
ASN EPC(@AsnEpc) 's Twitter Profile Photo

In this cohort study, the GLP-1 receptor agonist-SGLT-2 inhibitor combination was associated with a lower risk of major adverse cardiovascular events & serious renal events compared with either drug class alone bit.ly/3y28P65 @KatherineTuttle8 ChristosArgyropoulos MD, PhD PharmanukerInChief

account_circle
JASN_News(@JASN_News) 's Twitter Profile Photo

Patients with CKD are at higher risk of heart failure. This Podcast discusses findings that more first heart failure hospitalization events occurred in those treated with daprodustat than conventional ESA bit.ly/JPOD0321

Renato D Lopes thomas . Ajay Singh

Patients with CKD are at higher risk of heart failure. This Podcast discusses findings that more first heart failure hospitalization events occurred in those treated with daprodustat than conventional ESA bit.ly/JPOD0321 @RenatoDLopes1 @Thomas_Hiemstra @DoctorAjaySingh
account_circle
AJKD(@AJKDonline) 's Twitter Profile Photo

The articles in this Special Collection highlight various types of disparities that impact patients with kidney diseases and call attention to more research that is necessary to achieve the goal of global health equity.

buff.ly/2XYTLzz (FREE until June 30, 2024)

The articles in this Special Collection highlight various types of disparities that impact patients with kidney diseases and call attention to more research that is necessary to achieve the goal of global health equity. buff.ly/2XYTLzz (FREE until June 30, 2024)
account_circle
Kenar Jhaveri(@kdjhaveri) 's Twitter Profile Photo

Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology | Cardiorenal Medicine ⁦Rose Mary Attieh⁩ ⁦International Cardio-Oncology Society⁩ ⁦American Society of Onconephrology⁩ karger.com/crm/article/do…

account_circle
ASN Kidney News(@KidneyNews) 's Twitter Profile Photo

A large analysis of patients with ADPKD recently published in in BMC Nephrology finds differences in mortality risk for Black versus White patients aged 65 years or older bit.ly/3WnItFM

Kenar Jhaveri

A large analysis of patients with ADPKD recently published in in BMC Nephrology finds differences in mortality risk for Black versus White patients aged 65 years or older bit.ly/3WnItFM @kdjhaveri
account_circle
JASN_News(@JASN_News) 's Twitter Profile Photo

The May Issue of JASN is now available online!

Topics covered this month include:
-Uric acid lowering in CKD
-Kidney lymphatic response to AKI
and more! Explore the entire issue at journals.lww.com/jasn/pages/cur…

The May Issue of JASN is now available online! Topics covered this month include: -Uric acid lowering in CKD -Kidney lymphatic response to AKI and more! Explore the entire issue at journals.lww.com/jasn/pages/cur…
account_circle
Sayna Norouzi, MD, FASN(@SaynaNorouzi) 's Twitter Profile Photo

The patient has been diagnosed with IgAN, and this is the urine sample.

What do you estimate the proteinuria to be?

I'm usually pretty accurate with a standard deviation of ±0.5! 🤓

The patient has been diagnosed with IgAN, and this is the urine sample. What do you estimate the proteinuria to be? I'm usually pretty accurate with a standard deviation of ±0.5! 🤓#nephtwitter #MedTwitter
account_circle
AJKD(@AJKDonline) 's Twitter Profile Photo

In The Literature (Nature Communications) by Ashima Gulati and Marva Moxey-Mims:

Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving!

buff.ly/44dtr7v (FREE)

In The Literature (@NatureComms) by Ashima Gulati and Marva Moxey-Mims: Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving! buff.ly/44dtr7v (FREE)
account_circle
CJASN(@CJASN) 's Twitter Profile Photo

Anemia in patients with CKD is often treated with erythropoiesis-stimulating agents (ESAs), which increase the risk of major cardiovascular events. This Perspective argues that SGLT2 inhibitors should be considered as an alternative to existing approaches bit.ly/CJASN0362

account_circle
JASN_News(@JASN_News) 's Twitter Profile Photo

As CKD resembles accelerated aging, patients with CKD may benefit from klotho-focused aging research. This article discusses a novel klotho variant, a procedure to synthesize and purify the protein, and and assay to test its bioactivity bit.ly/JASN0388

Christian Faul

As CKD resembles accelerated aging, patients with CKD may benefit from klotho-focused aging research. This article discusses a novel klotho variant, a procedure to synthesize and purify the protein, and and assay to test its bioactivity bit.ly/JASN0388 @cfaul1
account_circle
Sayna Norouzi, MD, FASN(@SaynaNorouzi) 's Twitter Profile Photo

Just a while back, I crossed paths with this incredible lady battling IgAN and advanced CKD. From being a top pediatrician to a patient advocate, she's killing it! Loma Linda U. Health ❤️

Shoutout to National Kidney Foundation Silvi Shah, MD, MS for having us on board. Brittany's journey is truly inspiring! 🌟…

Just a while back, I crossed paths with this incredible lady battling IgAN and advanced CKD. From being a top pediatrician to a patient advocate, she's killing it! @LLUHealth ❤️ Shoutout to @nkf @silvishah for having us on board. Brittany's journey is truly inspiring! 🌟…
account_circle